Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-11

Clinical Trial Update: Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on piclozotan for motor complications in Parkinson's disease; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piclozotan (piclozotan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-03-11